
To achieve maximal efficacy within the complex biofilm microenvironment, nanoparticle carriers have shown increased interest in treating oral biofilms in recent years. The farnesol‐loaded NPCs (NPC+Far) resulted in a 2‐log CFU/mL reduction of S. mutans and C. albicans (hydroxyapatite disc biofilm model). High‐resolution confocal images further confirmed a significant reduction in exopolysaccharides, smaller microcolonies of S. mutans, and no hyphal form of C. albicans after treatment with NPC+Far on human tooth enamel (HT) slabs, altering the biofilm 3D structure. Drug delivery via polymeric NPCs has the potential for targeting bacterial‐fungal biofilms associated with a prevalent and costly pediatric oral disease, such as ECC.
Like
Save
Share